Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Manos

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Human Pathology|July 22, 1999
Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detectionB M Ronnett, M M Manos, J E Ransley, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2014
Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosisV Saxena, M M Manos, H S Yee, et al.
Journal of Clinical Microbiology|March 1, 1995
Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid captureM H Schiffman, N B Kiviat, R D Burk, et al.
The Journal of Pathology|August 19, 1999
Human papillomavirus is a necessary cause of invasive cervical cancer worldwideJ M Walboomers, M V Jacobs, M M Manos, et al.
American Journal of Clinical Pathology|August 1, 1994
Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus typesM E Sherman, M H Schiffman, A T Lorincz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1997
Evidence for at least two distinct groups of humoral immune reactions to papillomavirus antigens in women with squamous intraepithelial lesionsH D Strickler, M H Schiffman, C Eklund, et al.
The Journal of Infectious Diseases|November 22, 2000
A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV typesK L Liaw, A Hildesheim, R D Burk, et al.
The Journal of Infectious Diseases|October 9, 1999
Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesionsL Wideroff, M Schiffman, P Haderer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 26, 1998
Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United StatesA Hildesheim, M Schiffman, D R Scott, et al.
JAMA|May 11, 1999
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou resultsM M Manos, W K Kinney, L B Hurley, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Human Pathology|July 22, 1999
Atypical glandular cells of undetermined significance (AGUS): cytopathologic features, histopathologic results, and human papillomavirus DNA detectionB M Ronnett, M M Manos, J E Ransley, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2014
Telaprevir or boceprevir triple therapy in patients with chronic hepatitis C and varying severity of cirrhosisV Saxena, M M Manos, H S Yee, et al.
Journal of Clinical Microbiology|March 1, 1995
Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid captureM H Schiffman, N B Kiviat, R D Burk, et al.
The Journal of Pathology|August 19, 1999
Human papillomavirus is a necessary cause of invasive cervical cancer worldwideJ M Walboomers, M V Jacobs, M M Manos, et al.
American Journal of Clinical Pathology|August 1, 1994
Toward objective quality assurance in cervical cytopathology. Correlation of cytopathologic diagnoses with detection of high-risk human papillomavirus typesM E Sherman, M H Schiffman, A T Lorincz, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 1, 1997
Evidence for at least two distinct groups of humoral immune reactions to papillomavirus antigens in women with squamous intraepithelial lesionsH D Strickler, M H Schiffman, C Eklund, et al.
The Journal of Infectious Diseases|November 22, 2000
A prospective study of human papillomavirus (HPV) type 16 DNA detection by polymerase chain reaction and its association with acquisition and persistence of other HPV typesK L Liaw, A Hildesheim, R D Burk, et al.
The Journal of Infectious Diseases|October 9, 1999
Seroreactivity to human papillomavirus types 16, 18, 31, and 45 virus-like particles in a case-control study of cervical squamous intraepithelial lesionsL Wideroff, M Schiffman, P Haderer, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 26, 1998
Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United StatesA Hildesheim, M Schiffman, D R Scott, et al.
JAMA|May 11, 1999
Identifying women with cervical neoplasia: using human papillomavirus DNA testing for equivocal Papanicolaou resultsM M Manos, W K Kinney, L B Hurley, et al.
Pageof 6